The dramatic surge and sudden plunge in precious metal prices have thrown London's famed Hatton Garden into chaos, forcing jewellers, refiners, and families to navigate a volatile market with significant financial consequences.
London's blue-chip index surged to a historic high as investors rotated into defensive sectors, shrugging off a brutal sell-off in precious metals and oil triggered by geopolitical shifts and regulatory moves.
A broad sell-off in risk assets, from equities to precious metals, has triggered over $2.5 billion in Bitcoin liquidations. Analysts point to shifting Federal Reserve expectations and AI trade anxieties as key drivers behind the latest crypto market tremor.
A detailed look at the SPDR Gold Shares (GLD) and iShares Silver Trust (SLV) reveals a tale of two metals: one prized for stability, the other for its volatile potential. For investors navigating uncertain markets, the choice between them hinges on more than just recent returns.
Silver's explosive surge past $100 has reshaped the commodity landscape. With Citi and prominent strategists forecasting a run toward $150, the metal is now seen as a volatile barometer of macro fears, structural deficits, and relentless industrial demand, establishing a potential new floor above $65.
The Supreme Court of British Columbia has granted final approval for Coeur Mining's acquisition of New Gold, moving the deal into its final regulatory phase. The transaction, poised to significantly expand Coeur's precious metals footprint, advances as the miner's stock shows considerable strength over the past year.
Precious metals prices steadied on Monday following a sharp Friday plunge that rattled markets, though experts warn the volatility in these traditional safe havens may not be over.
Despite recent volatility in silver prices, Wheaton Precious Metals' unique streaming model positions it to generate robust cash flow, making it a standout choice for exposure to the precious metal.
Barclays initiates coverage with an Overweight rating and $20 price target on Altimmune, citing strong fundamentals and pipeline potential. The biotech firm prepares to channel recent offering proceeds toward its pivotal Phase 3 development for metabolic liver disease treatment pemvidutide.
Oracle is launching a massive $45-$50 billion capital raise to aggressively expand its cloud infrastructure, fueled by long-term contracts with AI giants like OpenAI, NVIDIA, and Meta. The move underscores the fierce competition in the cloud arms race, even as the company's stock faces recent headwinds.
A British Columbia court has given its final approval to Coeur Mining's planned acquisition of New Gold, moving the deal that will create a North American precious metals giant one step closer to its expected H1 2026 closing.
After a historic surge, gold prices have experienced their steepest drop in decades. Yet, analysts point to enduring geopolitical tensions and monetary policy shifts as reasons why the metal's long-term appeal remains intact.
Crude oil benchmarks plunged over 7%, with Brent near $66 and WTI around $62, as President Trump's comments eased fears of a U.S.-Iran conflict and a sell-off in metals markets spilled over. Analysts suggest the drop reflects a rapid unwinding of risk premiums rather than a fundamental change in supply dynamics.
As tech giants pour trillions into AI infrastructure, the insatiable demand for electricity is creating a new class of winners. NextEra Energy, America's largest utility, is emerging as a critical, if unexpected, backbone of the artificial intelligence boom through strategic partnerships with Alphabet and Meta.
Precious metals continue their sharp retreat from January's record highs, with silver leading the decline as market sentiment shifts following key U.S. policy signals.
Oil prices plunged and precious metals extended their historic sell-off as easing US-Iran tensions and President Trump's hawkish nominee for Federal Reserve Chair triggered a dramatic dollar rally, sending shockwaves through global markets.
Precious metals extended losses in Asian trading Monday, following a sharp sell-off triggered by speculation over a more hawkish Federal Reserve leadership. Despite the pullback, both gold and silver remain significantly higher for the year, supported by enduring central bank demand and geopolitical uncertainty.
Exelixis has filed its next-generation therapy zanzalintinib with U.S. regulators for metastatic colorectal cancer, marking a significant step in its clinical development and potentially enhancing its competitive position in the targeted oncology space.
Meta CEO Mark Zuckerberg's forecast of a major AI infrastructure build-out through 2026 suggests continued robust spending on Nvidia's hardware, reinforcing the chipmaker's central role in the ongoing tech boom.
Gilead Sciences (NasdaqGS:GILD) reported positive Phase 3 ASCENT-04/KEYNOTE-D19 results for Trodelvy plus Keytruda in first-line metastatic triple-negative breast cancer. Full Phase 3 clinical data were published in a leading medical journal, highlighting efficacy and safety outcomes for the combination regimen. Following these results, Gilead submitted supplemental regulatory filings to the FDA and EMA seeking expanded use of Trodelvy in this setting. For you as an investor, this update...
